Dr. LI Da received his master's degree in oncology from Zhejiang University School of Medicine in July 2000 and his doctoral degree in oncology from the same institute in July 2007. Since August 2007, he has worked at the SRRSH Department of Oncology. He has engaged in medical oncology for more than 20 years. He has rich clinical experience in chemotherapy, targeted therapy, immunobiotherapy, minimally invasive therapy and comprehensive therapy for various common solid tumors, especially in the individualized treatment of lung cancer and digestive tract tumors. He has participated in a number of global large-scale multi-center clinical research on new anticancer drugs. He has hosted and participated in a number of projects funded by the National Natural Science Foundation and Natural Science Foundation of Zhejiang Province. He has published more than 20 papers in Nature Communications, AFM, APSB, Biomacromolecules and other internationally renowned journals and domestic core journals and participated in the writing of Pharmaceutical Polymer Materials and other works.

Member, American Society of Clinical Oncology (ASCO)

Member, European Society of Medical Oncology (ESMO)

Member, CSCO Pancreatic Cancer Committee

Member of the Pancreatic Oncology Group, Chinese Society of Oncology

Deputy Director of the Bbiotherapeutic Professional Committee of the Zhejiang Anti-Cancer Association